Hints and tips:
Showing results for BERKHEIMER CO INC GW
...From a nuclear fleet of 50 reactors capable of producing some 47 GW of electricity and supplying over 30 per cent of Japan’s daily electricity needs at the beginning of 2011, the sector’s output shrank to...
...(WSJ $) It’s a big day for… GW Pharma The UK-based producer of non-hallucinogenic prescription cannabis reports fourth-quarter results and progress in expanding Sativex from pain relief to epilepsy, as...
...GW Pharmaceuticals jumped 14.6 per cent to 429p after the painkiller developer released encouraging early-stage data from a small trial of its Epidiolex drug to treat childhood epilepsy....
...According to Cowen & Co analysts, Allergan might draw up to $12bn of debt to fund a “bold transaction”....
...… Eric Schmidt Executive chairman of Google and co-author of ‘The New Digital Age (John Murray) An economist wrote in 1971 that, “in an information-rich world, the wealth of information means a dearth...
...This is the first in a series of approvals across Europe that triggers a £2.5m milestone payment to GW,” noted Paul Cuddon at Peel Hunt....
...It is a nominated adviser (nomad) to D1 Oils, GW Pharmaceuticals and IS Pharma who have until the end of the year to find replacements. The bank said it would help work through the transition process....
...Kenny, Partner, Momentum Corporate Finance LLP John Wakefield, Director of Corporate Finance, Blue Oar Securities Christopher Robinson, Chief Executive, RBR Group Richard Graves, Marketing Director, GWS...
...GW Pharmaceuticals added 3.9 per cent to 147 ½p on talk that next Thursday’s full-year results from the cannabis-based drugs maker would make pleasantreading....
International Edition